Volume 19, Number 6—June 2013
Synopsis
Zoonotic Mycobacterium bovis–induced Tuberculosis in Humans
Table 4
ID | Region | Country | HIV status | No. cases | No. tested | % | 95% CI | RR |
---|---|---|---|---|---|---|---|---|
1074 | Africa | Ethiopia | + | 4 | 10 | 40.0 | 12.2–73.8 | 1.43 |
1074 | Africa | Ethiopia | – | 7 | 25 | 28.0 | 12.1–49.4 | NA |
1147 | Africa | Tanzania | + | 2 | 29 | 6.9 | 0.8–22.8 | 0.50 |
1147 | Africa | Tanzania | – | 5 | 36 | 13.9 | 4.7–29.5 | NA |
NA | Africa | Total | + | 6 | 39 | 15.4 | 5.9–30.5 | 0.78 |
NA | Africa | Total | – | 12 | 61 | 19.7 | 10.6–31.8 | NA |
57 | Americas | Argentina | + | 2 | 240 | 0.8 | 0.1–3.0 | 0.88 |
57 | Americas | Argentina | – | 95 | 10,000 | 1.0 | 0.8–1.2 | NA |
57 | Americas | Argentina | + | 8 | 1,391 | 0.6 | 0.2–1.1 | 2.66 |
57 | Americas | Argentina | – | 12 | 5,551 | 0.2 | 0.1–0.4 | NA |
39 | Americas | Mexico | + | 11 | 80 | 13.8 | 7.1–23.3 | 1.90 |
39 | Americas | Mexico | – | 6 | 83 | 7.2 | 2.7–15.1 | NA |
46 | Americas | USA | + | 21 | 891 | 2.4 | 1.5–3.6* | 2.59 |
46 | Americas | USA | – | 59 | 6,472 | 0.9 | 0.7–1.2* | NA |
48 | Americas | USA | + | 33 | 140 | 23.6 | 16.8–31.5* | 3.24 |
48 | Americas | USA | – | 48 | 659 | 7.3 | 5.4–9.5* | NA |
164 | Americas | USA | + | 39 | 64 | 60.9 | 47.9–72.9* | 8.32 |
164 | Americas | USA | – | 35 | 478 | 7.3 | 5.2–10.0* | NA |
NA | Americas | Total | + | 114 | 2806 | 4.1 | 3.4–4.9* | 3.70 |
NA | Americas | Total | – | 255 | 23,243 | 1.1 | 1.0–1.2* | N/A |
*TB, tuberculosis; ID, Record identification number (Technical Appendix 2); Cases, number of zoonotic tuberculosis (TB) cases identified; Tested, number of TB cases tested for the presence of M. bovis infection; %, proportion of zoonotic TB among all TB cases; RR, relative risk ratio; NA, not available.
Significantly higher proportion of M. bovis infection among TB patients with HIV coinfection.
Page created: May 21, 2013
Page updated: May 21, 2013
Page reviewed: May 21, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.